These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9133501)

  • 21. [Pharmaco-economical aspects of reduction of left ventricular hypertrophy in hypertensive patients: how we can use the results of clinical trials].
    Petrov VI; Nedogoda SV; Sabanov AV
    Kardiologiia; 2004; 44(2):104-7. PubMed ID: 15125435
    [No Abstract]   [Full Text] [Related]  

  • 22. Lisinopril reverses left ventricular hypertrophy through improved aortic compliance.
    Shimamoto H; Shimamoto Y
    Hypertension; 1996 Sep; 28(3):457-63. PubMed ID: 8794833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
    Nyström F; Malmqvist K; Ohman KP; Kahan T
    J Hypertens; 2002 Aug; 20(8):1527-33. PubMed ID: 12172314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression.
    Cohen A; Bregman B; Agabiti Rosei E; Williams B; Dubourg O; Clairefond P; Brudi P; Gosse P; Guéret P
    J Hum Hypertens; 1998 Jul; 12(7):479-83. PubMed ID: 9702935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of left ventricular hypertrophy: some alternate thoughts.
    Agarwal R
    Am J Kidney Dis; 2005 Dec; 46(6):1148; author reply 1148-9. PubMed ID: 16310583
    [No Abstract]   [Full Text] [Related]  

  • 27. [Regression of left ventricular hypertrophy with antihypertensive therapy].
    Follath F
    Ther Umsch; 1998 Sep; 55(9):539-41. PubMed ID: 9789465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A; D'Agostino RB; Silbershatz H; Sytkowski PA; Kannel WB; Grobbee DE; Levy D
    N Engl J Med; 1999 Apr; 340(16):1221-7. PubMed ID: 10210704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertension Prevalence, Cardiac Complications, and Antihypertensive Medication Use in Children.
    Dobson CP; Eide M; Nylund CM
    J Pediatr; 2015 Jul; 167(1):92-7.e1. PubMed ID: 25957976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal antihypertensive therapy for prevention and treatment of left ventricular hypertrophy.
    Liebson PR; Serry RD
    Curr Hypertens Rep; 2000 Jun; 2(3):260-70. PubMed ID: 10981159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians.
    Massie BM
    J Card Fail; 2002 Aug; 8(4):197-201. PubMed ID: 12397565
    [No Abstract]   [Full Text] [Related]  

  • 32. What can we expect in antihypertensive drug therapy?
    van Zwieten PA
    Curr Opin Cardiol; 1994 Sep; 9(5):568-72. PubMed ID: 7987036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of left ventricular hypertrophy.
    Fagard R
    JAMA; 1996 Nov; 276(20):1636-7. PubMed ID: 8922446
    [No Abstract]   [Full Text] [Related]  

  • 34. [Left ventricular hypertrophy in paediatric predialysis children and treatment--induced regression of left ventricular mass].
    Borzych D; Zurowska A; Bałasz I; Sabiniewicz R; Ereciński J
    Wiad Lek; 2005; 58 Suppl 1():55-7. PubMed ID: 16060086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-drug therapy and reduction of left ventricular mass in hypertension.
    Gottdiener JS
    Cardiologia; 1998 Nov; 43(11):1177-83. PubMed ID: 9922583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of antihypertensive drug treatment on the prevention and regression of left ventricular hypertrophy.
    van Zwieten PA
    Cardiovasc Res; 2000 Jan; 45(1):82-91. PubMed ID: 10728317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the treatment with amlodipine on left ventricular hypertrophy in hypertensive patients].
    Oliván J; Moreno R; Hoyos M; Ramos E; Rodríguez A; Pizarro JL; Justo E; Pérez Cano R
    An Med Interna; 1996 Nov; 13(11):531-6. PubMed ID: 9019211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Decreasing the antihypertensive dosage during longterm treatment and complete regression of left ventricular hypertrophy].
    Franz IW; Behr U; Ketelhut R; Tönnesmann U
    Dtsch Med Wochenschr; 1996 Apr; 121(15):472-7; discussion 478. PubMed ID: 8605839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of the perindopril or irbesartan combined with diltiazem on left ventricular hypertrophy in outpatient mild to moderate hypertensive subjects.
    Chang Y; Ding Y
    Hellenic J Cardiol; 2021; 62(4):324-325. PubMed ID: 32931921
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
    Schmieder RE; Schlaich MP
    Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.